Pnina Fishman

Pnina Fishman

Company: CanFite

Job title: Chief Executive Officer


A Phase 2a Dosefinding Study of Namodenoson, an A3AR Agonist, in Non-alcoholic Fatty Liver Disease and Non-alcoholic Steatohepatitis 1:30 pm

• General background of our target • Revealing our protocol and study results • How we designed our Phase 2a trialRead more

day: Day 2 Stream 3 PM

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.